{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:16:26Z","timestamp":1782324986165,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.genhosppsych.2024.06.015","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T17:36:59Z","timestamp":1720114619000},"page":"76-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A pilot study on in-utero exposure to psychotropic drugs: A comparison of pharmacological classes on neonatal and maternal outcomes"],"prefix":"10.1016","volume":"90","author":[{"given":"Elvera A.","family":"Damer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demi","family":"van Kampen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille A.","family":"Edens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke A.C.","family":"Hemels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas S.W.A. Nij","family":"Bijvank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.J.","family":"ter Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00737-020-01024-0","article-title":"Prevalence and determinants of antenatal common mental disorders among women in India: a systematic review and meta-analysis","volume":"24","author":"Kalra","year":"2021","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12884-019-2572-4","article-title":"Prevalence of self-reported mental disorders in pregnancy and associations with adverse neonatal outcomes: a population-based cross-sectional study","volume":"19","author":"Mongan","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0015","first-page":"805","article-title":"Psychiatric disorders in pregnant and postpartum women in the United States","volume":"65","author":"Vesga-Lopez","year":"2008","journal-title":"ArchGenPsychiatry"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0020","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/birt.12343","article-title":"Depression and anxiety during pregnancy: the influence of maternal characteristics","volume":"45","author":"van de Loo","year":"2018","journal-title":"Birth"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0025","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/AOG.0000000000004538","article-title":"Associations between maternal depression, antidepressant use during pregnancy, and adverse pregnancy outcomes: an individual participant data Meta-analysis","volume":"138","author":"Vlenterie","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0029-1225529","article-title":"Pregnancy outcome of patients with schizophrenia","volume":"27","author":"Hizkiyahu","year":"2010","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0035","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00404-019-05075-2","article-title":"Epidemiology of mental disorders during pregnancy and link to birth outcome: a large-scale retrospective observational database study including 38,000 pregnancies","volume":"299","author":"Wallwiener","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpsychires.2020.02.023","article-title":"Use of antidepressants during pregnancy and neonatal outcomes: an umbrella review of meta-analyses of observational studies","volume":"124","author":"Biffi","year":"2020","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-016-1127-1","article-title":"Bipolar disorder in pregnancy and childbirth: a systematic review of outcomes","volume":"16","author":"Rusner","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/acps.13441","article-title":"Hypnotic benzodiazepine receptor agonist exposure during pregnancy and the risk of congenital malformations and other adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"146","author":"Grigoriadis","year":"2022","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0055","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.4088\/JCP.15r10483","article-title":"A systematized review of atypical antipsychotics in pregnant women: balancing between risks of untreated illness and risks of drug-related adverse effects","volume":"78","author":"Tosato","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0060","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/aje\/kwr394","article-title":"Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?","volume":"175","author":"Palmsten","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0065","first-page":"353","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","author":"Bartsch","year":"2016","journal-title":"The BMJ"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0070","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/acr.21807","article-title":"Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia","volume":"64","author":"Palmsten","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0075","first-page":"1","article-title":"Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia","volume":"12","author":"Shen","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.preghy.2017.11.004","article-title":"Indications for delivery in pre-eclampsia","volume":"11","author":"Varnier","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/aje\/155.3.203","article-title":"Impact of preeclampsia and gestational hypertension on birth weight by gestational age","volume":"155","author":"Xiong","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/7953289","article-title":"Effect of maternal preeclampsia on hematological profile of newborns in Qatar","volume":"2020","author":"Bayoumi","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0095","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00737-016-0655-z","article-title":"Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy","volume":"19","author":"De Ocampo","year":"2016","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0100","doi-asserted-by":"crossref","first-page":"406.e1","DOI":"10.1016\/j.ajog.2007.06.059","article-title":"Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation","volume":"197","author":"Habli","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ajh.2008.366","article-title":"Preeclampsia risk in relation to maternal mood and anxiety disorders diagnosed before or during early pregnancy","volume":"22","author":"Qiu","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0110","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","article-title":"Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks\u2019 gestation (HYPITAT): a multicentre, open-label randomised controlled trial","volume":"374","author":"Koopmans","year":"2009","journal-title":"The Lancet"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0115","doi-asserted-by":"crossref","first-page":"540.e1","DOI":"10.1016\/j.ajog.2011.07.003","article-title":"Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37 weeks of gestation: a 7 year retrospective analysis of a national registry","volume":"205","author":"Langenveld","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0120","series-title":"The impact of maternal prenatal mental health disorders on stillbirth and infant mortality: a systematic review and meta-analysis","author":"Adane","year":"2024"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/AOG.0000000000004538","article-title":"Associations between maternal depression, antidepressant use during pregnancy, and adverse pregnancy outcomes: an individual participant data Meta-analysis","volume":"138","author":"Vlenterie","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0130","series-title":"Hypertensive disorders during pregnancy.[Hypertensieve aandoeningen in de zwangerschap]","author":"NVOG","year":"2021"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0135","doi-asserted-by":"crossref","first-page":"570","DOI":"10.32614\/RJ-2021-053","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R Journal"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0140","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: The R package dagitty","volume":"45","author":"Textor","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0145","first-page":"8","article-title":"Reducing bias through directed acyclic graphs","author":"Shrier","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0150","series-title":"RStudio","author":"RStudio Team","year":"2020"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0155","doi-asserted-by":"crossref","unstructured":"Suttajit S, Srisurapanont M, Xia J, Suttajit S, Maneeton B, Maneeton N. Quetiapine versus typical antipsychotic medications for schizophrenia. Cochrane Database Syst Rev 2013;2013. Doi: https:\/\/doi.org\/10.1002\/14651858.CD007815.pub2.","DOI":"10.1002\/14651858.CD007815.pub2"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/JCP.0000000000000665","article-title":"Activating and sedating adverse effects of second-generation antipsychotics in the treatment of schizophrenia and major depressive disorder: absolute risk increase and number needed to harm","volume":"37","author":"Citrome","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0165","series-title":"Depression in adults: treatment and management NICE guideline","year":"2022"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0170","series-title":"Generalised anxiety disorder and panic disorder in adults: management Clinical guideline","year":"2011"},{"key":"10.1016\/j.genhosppsych.2024.06.015_bb0175","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/bcp.15609","article-title":"Adherence to prescription medication during pregnancy: do pregnant women use pharmacological treatment as prescribed?","volume":"89","author":"de Korte","year":"2023","journal-title":"Br J Clin Pharmacol"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834324001543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834324001543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T17:43:57Z","timestamp":1725990237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834324001543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":35,"alternative-id":["S0163834324001543"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2024.06.015","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot study on in-utero exposure to psychotropic drugs: A comparison of pharmacological classes on neonatal and maternal outcomes","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2024.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}